Comment
doi: 10.2337/db08-1007.
Big mac attack: does it play a direct role for monocytes/macrophages in type 1 diabetes?
Affiliations
- PMID: 18971442
- PMCID: PMC2570387
- DOI: 10.2337/db08-1007
Item in Clipboard
Comment
Big mac attack: does it play a direct role for monocytes/macrophages in type 1 diabetes?
Diabetes.
2008 Nov.
No abstract available
Figures
Arrow indicates a circulating monocyte on peripheral blood smear.
Comment on
-
Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes.Diabetes. 2008 Nov;57(11):3025-33. doi: 10.2337/db08-0625. Epub 2008 Jul 15. Diabetes. 2008. PMID: 18633103 Free PMC article.
Similar articles
-
CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile.J Immunol. 2014 Apr 15;192(8):3858-67. doi: 10.4049/jimmunol.1302821. Epub 2014 Mar 17. J Immunol. 2014. PMID: 24639350
-
Antibody to Mac-1 or monocyte chemoattractant protein-1 inhibits monocyte recruitment and promotes tumor growth.J Immunol. 1997 May 15;158(10):4855-61. J Immunol. 1997. PMID: 9144501
-
Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.Arthritis Rheum. 2001 May;44(5):1022-32. doi: 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N. Arthritis Rheum. 2001. PMID: 11352233
-
Macrophages and monocytes in 2017: Macrophages and monocytes: of tortoises and hares.Nat Rev Immunol. 2018 Feb;18(2):85-86. doi: 10.1038/nri.2017.158. Epub 2018 Jan 2. Nat Rev Immunol. 2018. PMID: 29292392 Review. No abstract available.
-
The chemokine system in arteriogenesis and hind limb ischemia.J Vasc Surg. 2007 Jun;45 Suppl A(Suppl A):A48-56. doi: 10.1016/j.jvs.2007.02.030. J Vasc Surg. 2007. PMID: 17544024 Free PMC article. Review.
Cited by
-
Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases.Clin Immunol. 2016 Dec;173:81-86. doi: 10.1016/j.clim.2016.09.005. Epub 2016 Sep 9. Clin Immunol. 2016. PMID: 27620642 Free PMC article. Review.
-
Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus.Br J Pharmacol. 2017 Jul;174(13):2074-2084. doi: 10.1111/bph.13816. Epub 2017 May 30. Br J Pharmacol. 2017. PMID: 28409821 Free PMC article.
-
Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development.Cells. 2022 Nov 4;11(21):3503. doi: 10.3390/cells11213503. Cells. 2022. PMID: 36359899 Free PMC article. Review.
-
Immune cell crosstalk in type 1 diabetes.Nat Rev Immunol. 2010 Jul;10(7):501-13. doi: 10.1038/nri2787. Nat Rev Immunol. 2010. PMID: 20577267 Review.
-
Teplizumab therapy for type 1 diabetes.Expert Opin Biol Ther. 2010 Mar;10(3):459-65. doi: 10.1517/14712591003598843. Expert Opin Biol Ther. 2010. PMID: 20095914 Free PMC article. Review.
References
-
- Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 85: 291–297, 1996 - PubMed
-
- Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358: 221–229, 2001 - PubMed
-
- Bach JF: Autoimmunity and type I diabetes. Trends Endocrinol Metab 8: 71–74, 1997 - PubMed
-
- Roep BO: The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46: 305–321, 2003 - PubMed
-
- Goudy KS, Tisch R: Immunotherapy for the prevention and treatment of type 1 diabetes. Int Rev Immunol 24: 307–326, 2005 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
